This inventor holds 2 USPTO granted patents. Top assignees: Common Services Agency, Medical Defense Technology, LLC. Active years: 1999-2004.
Company Filing History:
Years Active: 1999-2004
Title: Innovations of George Robin Barclay
Introduction
George Robin Barclay is a notable inventor based in Midlothian, GB. He has made significant contributions to the field of immunology, particularly in the development of vaccines and monoclonal antibodies. With a total of two patents to his name, his work has the potential to impact the medical community significantly.
Latest Patents
Barclay's latest patents include a vaccine against lipopolysaccharide core and a monoclonal antibody against LPS core. The vaccine is designed to incorporate core LPS from Gram-negative bacteria into liposomes, stimulating the synthesis of antibodies that are cross-protective against various bacterial strains. His monoclonal antibody invention provides antibodies that are effective against endotoxemia caused by different Gram-negative bacterial strains, utilizing the Kohler/Milstein procedure for production.
Career Highlights
Throughout his career, George Robin Barclay has worked with several organizations, including Medical Defense Technology, LLC and the Common Services Agency. His expertise in immunology and vaccine development has positioned him as a valuable contributor to the field.
Collaborations
Barclay has collaborated with notable individuals such as Ian Raymond Poxton and Elliott Bennett-Guerrero. These partnerships have likely enhanced his research and development efforts in the medical field.
Conclusion
George Robin Barclay's innovative work in vaccine and antibody development showcases his commitment to advancing medical science. His contributions are essential in the ongoing fight against bacterial infections and endotoxemia.